In reply,

With great curiosity we have read the letter to editor by Bongomin F. and colleagues[@R1] written as a comment to our recent published article in African Health Sciences[@R2], we appreciate their interest to our article and inputs. The interest of the study was to investigate the risk factors for esophageal candidiasis (EC). The risk factors are clearly indicated in the original manuscript regardless of HIV status[@R1]. In addition, HIV was also analysed as one of the risk factor as previously reported elsewhere [@R3],[@R4]. The increase in age was found to protect the patients from developing EC as previous published[@R5]. In order not to confuse the reader, the odd ratio and 95%confidence interval for age variable in Table 2 in the original article[@R1] was reversed to show the decrease in age as the risk of EC and presented in the abstract and content of the original manuscript[@R1].

In addition, in this letter to editor we have included results regarding factors associated with EC in HIV negative individuals. Of 554 HIV negative patients, 20(3.6%) had EC. On multivariate logistic regression analysis, increase in age independently protected HIV negative population from getting EC (OR 0.95, 95%CI; 0.92--0.99; p=0.0035), whilebeing female (OR 11.74, 95%CI; 1.55--88.82; p=0.017), alcohol use(OR 20.45, 95%CI; 4.89--86.56; \<=0.001), smoking(OR 5.44, 95%CI; 1.18--25.12; p=0.03), antibiotic use(OR 5.2, 95%CI; 1.67--16.21; p\<0.005), and having peptic ulcer diseases (OR 8.24, 95%CI; 2.21--30.72; p\<0.002) independently predicted EC among HIV negative patients ([table 4](#T4){ref-type="table"}).

###### 

Risk factors associated with esophageal candidiasis among HIV negative patients attending e ndoscopy unit (n=554)

  -------------------------------------------------------------------------------------------------
  Variable              Univariate   Multivariate                                         
  --------------------- ------------ --------------------- --------- -------------------- ---------
  **Age**\*             3931--50     0.99(0.96--1.02)      0.365     0.95(0.92--0.99)     0.035

  **Sex**                                                                                 

  Male (307)            11(3.6)      1                                                    

  Female (247)          9(3.6)       1.02(0.414--2.496)    0.97      11.74(1.55--88.82)   0.017

  **Alcohol**                                                                             

  No (475)              6(1.3)       1                                                    

  Yes (79)              14(17.7)     16.8(6.25--45.35)     \<0.001   20.45(4.89--86.56)   \<0.001

  **Smoking**                                                                             

  No (515)              13(2.5)      1                                                    

  Yes (39)              7(18)        8.45(3.15--22.64)     \<0.001   5.44(1.18--25.12)    0.03

  **Corticosteroid**\                                                                     
  **use**                                                                                 

  No (551)              18(3.3)      1                                                    

  Yes (3)               2(66.7)      59.2(5.13--683.5)     0.001     −                    −

  **Clinical**\                                                                           
  **presentation**                                                                        

  No (241)              3(1.2)       1                                                    

  Yes (313)             17(5.43)     4.56(1.32--15.73)     0.016     3.90(0.90--16.85)    0.068

  **Antibiotics use**                                                                     

  No (448)              9(2.01)      1                                                    

  Yes (106)             11(10.38)    5.64(2.27--14.01)     \<0.001   5.2(1.67--16.21)     0.005

  **Diabetic**                                                                            

  Negative (542)        14(2.6)      1                                                    

  Positive (12)         6(50.0)      37.7(10.81--131.62)   \<0.001   −                    −

  **PUD**                                                                                 

  No (473)              13(2.8)      1                                                    

  Yes (81)              7(8.6)       3.35(1.29--8.66)      0.013     8.24(2.21--30.72)    0.002

  **Asthma**                                                                              

  No (550)              18(3.27)     1                                                    

  Yes (4)               2(50.0)      29.56(3.94--221.79)   0.001     −                    −
  -------------------------------------------------------------------------------------------------

PUD is the peptic ulcer diseases; some known variable like use of corticosteroid, having diabetic and asthma were not include in multivariate analysis because the patients with EC were very few which could lead to a very wide confidence interval.

Furthermore, we have noted that, the original published article did not incorporate the corrections which were presented during proofreading, for this reason we have presented the correct [table 3](#T3){ref-type="table"} as seen below:

###### 

Characteristics of HIV negative patients with EC

  S/number   Sex      Age   Presentation   Alcohol   Smoking   Antibiotic   Diabetic   Cirrhosis   PUD   Asthma
  ---------- -------- ----- -------------- --------- --------- ------------ ---------- ----------- ----- --------
  1          Male     20    Hemoptysis     Yes       Yes       No           No         Yes         No    No
  2          Female   24    Ep. pain       No        No        Yes          No         No          Yes   No
  3          Male     32    Ep. Pain       Yes       Yes       Yes          No         No          No    No
  4          Female   30    Ep. Pain       Yes       No        Yes          No         No          No    No
  5          Male     47    Dysphagia      Yes       Yes       Yes          Yes        No          No    No
  6          Female   17    Dysphagia      No        No        No           No         No          No    Yes
  7          Male     40    Ep. pain       Yes       No        Yes          No         No          Yes   No
  8          Female   38    Ep. pain       Yes       No        No           Yes        No          No    No
  9          Female   47    Ep. pain       No        No        No           Yes        No          No    No
  10         Male     77    Ep. pain       Yes       Yes       Yes          No         No          No    No
  11         Female   38    Ep. pain       No        No        Yes          No         No          Yes   No
  12         Male     34    UGIB           Yes       Yes       No           No         No          Yes   No
  13         Female   60    Ep. pain       Yes       No        Yes          No         No          Yes   No
  14         Male     28    Ep. pain       Yes       Yes       No           No         No          No    No
  15         Male     40    Dysphagia      Yes       No        No           Yes        No          Yes   No
  16         Male     36    Ep. pain       Yes       No        Yes          Yes        No          No    No
  17         Male     44    UGIB           Yes       Yes       No           No         Yes         No    No
  18         Female   62    Ep. pain       No        No        No           Yes        No          No    No
  19         Female   33    Ep. pain       Yes       No        Yes          No         No          Yes   No
  20         Male     23    Ep. pain       No        No        Yes          No         No          No    Yes

Note; Ep. Pain is epigastric pain and UGIB is upper gastro intestinal bleeding
